Octreotide (brand name Sandostatin, Novartis Pharmaceuticals) is an octapeptide that mimics natural somatostatin pharmacologically, though it is a more potent inhibitor of growth hormone, glucagon, and insulin than the natural hormone. It was first synthesized in 1979 by the chemist Wilfried Bauer.
9 edits since May 19, 2008. Last edited Jul 23, 2008 by Meodipt (143).
This Compound Monograph is licensed under the GNU Free Documentation License and uses material from the Wikipedia article Octreotide. See this site's terms for details.